Amid Signs of a Covid Uptick, Researchers Brace for the ‘New Normal’
Infections remain very low, despite signs of a slight increase. Now, experts are looking for clues to what living with the coronavirus will be like this winter and beyond. (Source: NYT Health)
Source: NYT Health - August 2, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Deaths (Fatalities) Coronavirus (2019-nCoV) Vaccination and Immunization Disease Rates Coronavirus Omicron Variant Influenza Winter (Season) Respiratory Syncytial Virus (RSV) Source Type: news
Universal Flu Vaccine Candidate Shows Promise in Mid-Stage Trial
(MedPage Today) -- An investigational vaccine that contains the nucleoprotein of the influenza A virus appeared promising as a universal flu shot that could protect against multiple strains, regardless of annual mutations, a phase IIa dose-finding... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 2, 2023 Category: American Health Source Type: news
Health Officials and Clinical Labs Gear Up to Deal with Another ‘ Tripledemic ’
In preparing to deal with outbreaks of three different respiratory viruses, measures include newly approved vaccines for RSV and reformulated COVID-19 shots Clinical laboratories are the frontline of testing for respiratory infections, and as such, were heavily involved in last winter’s so-called “tripledemic” of Influenza, SARS-CoV-2, and respiratory syncytial virus (RSV). According to a Kaiser […]
The post Health Officials and Clinical Labs Gear Up to Deal with Another ‘Tripledemic’ appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - July 31, 2023 Category: Laboratory Medicine Authors: swallask Tags: Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Source Type: news
QuickStats: Percentage of Adults Aged ≥18 Years who Received an Influenza Vaccination in the Past 12 Months, by Race and Ethnicity and Family Income - National Health Interview Survey, United States, 2021
This report describes the percentage of adults who received an influenza vaccine in the past 12 months. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 27, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Efforts To Protect Condors From Avian Influenza Move A Step Closer
Vaccine to protect California condors against highly pathogenic avian influenza appears to be safe. More birds now will be vaccinated and antibody levels monitored. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 24, 2023 Category: Pharmaceuticals Authors: Dave Wessner, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Is a ‘polyepidemic’ humanity’s next big threat? Childhood vaccine crusader shares concerns for future
By the start of 2011, the year epidemiologist Seth Berkley became CEO of Gavi, the Vaccine Alliance, the ambitious nonprofit had over its 11-year history supported the immunization of 288 million children in poor countries. But it also had a $3.7 billion funding gap between its plans and donor financial pledges. Making matters worse, an internal battle raged about how much it should invest in strengthening health systems versus more technological solutions, such as new or improved vaccines, favored by its main funder, the Bill & Melinda Gates Foundation. “It was a crisis,” Berkley says.
Berkley plans to step ...
Source: ScienceNOW - July 20, 2023 Category: Science Source Type: news
RSV vaccine for older adults approved by UK medicines regulator
Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each yearThe UK ’s medicines regulator has approved the first vaccine against respiratory syncytial virus (RSV) in older adults.The virus typically causes cold-like symptoms, but is aleading cause of pneumonia in infants and elderly people, with infections in older adults accounting for about 8,000 deaths, 14,000 hospitalisations and 175,000 GP appointments in the UK each year –more than influenza during a typical winter season.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 10, 2023 Category: Science Authors: Linda Geddes Science correspondent Tags: Vaccines and immunisation Health Drugs Society Medical research GlaxoSmithKline Science UK news Older people Source Type: news
As Highly Pathogenic Avian Influenza Viruses Threaten California Condors, A Vaccine May Be The Answer
Endangered California condors are threatened by highly pathogenic avian influenza viruses. An ongoing study explores the efficacy of vaccines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 10, 2023 Category: Pharmaceuticals Authors: Dave Wessner, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science standard Source Type: news
Federal Officials Hatch a Three-Pronged Defense Against Another ‘Tripledemic’
This fall, Americans will be urged to get shots against the flu, Covid and, if they ’re older, R.S.V. (Source: NYT Health)
Source: NYT Health - July 5, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Vaccination and Immunization Deaths (Fatalities) Elderly Coronavirus (2019-nCoV) Guillain-Barre Syndrome Respiratory Syncytial Virus (RSV) Influenza Winter (Season) GSK PLC Pfizer Inc Clinical Trials Source Type: news
Three Vaccines for Fall: What You Need to Know
Here ’s who should get the flu, Covid and R.S.V. vaccines, and when. (Source: NYT Health)
Source: NYT Health - July 5, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Vaccination and Immunization Coronavirus (2019-nCoV) Guillain-Barre Syndrome Elderly Influenza Respiratory Syncytial Virus (RSV) Immune System Viruses Winter (Season) GSK PLC Moderna Inc Novavax Inc Pfizer Inc Source Type: news
AI? Brain manipulation? WHO ’s new chief scientist aims to anticipate global challenges
At the beginning of May, after almost 10 years at the helm of one of the world’s richest biomedical foundations, British physician Jeremy Farrar traded funding clout for a bigger international stage, moving to Geneva to become chief scientist at the World Health Organization (WHO). Farrar had
helped make the U.K.-based Wellcome Trust a major player
in global issues such as infectious diseases and the health effects of climate change. He also wasn’t shy about criticizing WHO’s leadership, specifically its slow response to the West African Ebola outbreak in 2014.
Only the second person in the chief scie...
Source: ScienceNOW - June 29, 2023 Category: Science Source Type: news
Sanofi says it's back to the drawing board on mRNA flu vaccines
Sanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective against influenza. The company is working on a next-generation flu shot based on mRNA, which showed a strong immune response against A strains but not against less prevalent B strains. Sanofi aims to upgrade the technology to improve the immune response against B strains and enhance the durability of the vaccine at normal fridge temperatures. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 29, 2023 Category: Pharmaceuticals Source Type: news
The COVID-19 Vaccine Is Likely Getting an Update
In a unanimous vote, the 21 members of the U.S. Food and Drug Administration (FDA)’s vaccine committee recommended an update to the COVID-19 vaccine to better match the viral strains currently circulating in the country and around the world.
The panel voted to move away from the current bivalent vaccine, which is designed to tackle the original virus and BA.4 and BA.5 variants, to a vaccine that is better able to protect against the XBB family of variants. The half a dozen different versions of XBB viruses account for nearly all new infections in the U.S., with two—XBB.1.5 and XBB.1.16—currently dominatin...
Source: TIME: Health - June 15, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
The COVID-19 Vaccine Is Getting an Update. Here ’ s What to Know
In a unanimous vote, the 21 members of the U.S. Food and Drug Administration (FDA)’s vaccine committee recommended an update to the COVID-19 vaccine to better match the viral strains currently circulating in the country and around the world.
The panel voted to move away from the current bivalent vaccine, which is designed to tackle the original virus and BA.4 and BA.5 variants, to a vaccine that is better able to protect against the XBB family of variants. The half a dozen different versions of XBB viruses account for nearly all new infections in the U.S., with two—XBB.1.5 and XBB.1.16—currently dominatin...
Source: TIME: Health - June 15, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Could chatbots help devise the next pandemic virus?
Tech experts have been sounding the alarm that artificial intelligence (AI) could turn against humanity by taking over everything from business to warfare. Now, Kevin Esvelt is adding another worry: AI could help somebody with no science background and evil intentions design and order a virus capable of unleashing a pandemic.
Esvelt, a biosecurity expert at the Massachusetts Institute of Technology, recently asked students to create a dangerous virus with the help of ChatGPT or other so-called large language models, systems that can generate humanlike responses to broad questions based on vast training sets of intern...
Source: ScienceNOW - June 14, 2023 Category: Science Source Type: news
